arrow
M

Mirjana Ziemer

university hospital leipzig
H指数:32
被引数:4,071

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

S1-Leitlinie Schweißdrüsenkarzinom

S1临床指南:汗腺癌

2026-09-080
OAAI
S1 guideline sweat gland carcinoma

S1指南汗腺癌

2026-07-070
OAAI
Avelumab plus cetuximab in patients with unresectable stage III or IV cutaneous squamous cell carcinoma: clinical activity and safety results from AliCe, a single-arm multicentre phase II DeCOG trial

阿维鲁姆单抗联合西妥昔单抗用于不可切除的III期或IV期皮肤鳞状细胞癌患者的临床活性和安全性结果:来自AliCe这一单臂多中心DeCOG II期试验的数据

2025-09-012
PRE
Sex-specific survival in advanced metastatic melanoma – a DeCOG study on 2032 patients of the multicenter prospective skin cancer registry ADOREG

晚期转移性黑色素瘤的性别特异性生存率——一项DeCOG研究,涉及ADOREG多中心前瞻性皮肤癌登记研究的2032例患者。

2025-07-290
OA
Lifileucel tumor-infiltrating lymphocyte cell therapy in patients with unresectable or metastatic mucosal melanoma after disease progression on immune checkpoint inhibitors

利菲鲁赛(Lifileucel)肿瘤浸润淋巴细胞细胞疗法在免疫检查点抑制剂治疗后疾病进展的不可切除或转移性黏膜黑色素瘤患者中的应用

2025-07-220
OAAI
Neoadjuvant Intralesional Targeted Immunocytokines (Daromun) in Stage III Melanoma.

新辅助病灶内靶向免疫细胞因子(Daromun)在III期黑色素瘤中的应用。

2025-07-070
PREAI
Single-cell transcriptomics and epigenomics point to CD58-CD2 interaction in controlling primary melanoma growth and immunity

单细胞转录组学和表观基因组学指向CD58-CD2相互作用在调控原发黑色素瘤生长和免疫中的作用

2025-01-150
OAAI
S3 guideline: Diagnosis and treatment of epidermal necrolysis(Stevens-Johnson syndrome and toxic epidermal necrolysis) -Part 2: Supportive therapy of EN in the acute and post-acute stages

S3指南: 表皮坏死松解症 (stevens-johnson综合征和中毒性表皮坏死松解症) 的诊断和治疗.第2部分: 急性和急性后阶段EN的支持治疗

2024-11-070
OAAI
S3 guideline: Diagnosis and treatment of epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis) - Part 2: Supportive therapy of EN in the acute and post-acute stages
2024-10-170
OAAI
S3-Leitlinie: Diagnostik und Therapie der epidermalen Nekrolyse (Stevens-Johnson-Syndrom und toxisch epidermale Nekrolyse) - Teil 1: Diagnostik, initiales Management und immunmodulierende Systemtherapie

S3指南:表皮坏死(Stevens-Johnson综合征和中毒性表皮坏死)的诊断与治疗——第1部分:诊断、初始管理和免疫调节系统性治疗

2024-10-110
OAAI
S3 guideline: Diagnosis and treatment of epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis) - Part 1: Diagnosis, initial management, and immunomodulating systemic therapy
2024-09-230
OAAI
Early switch from targeted to immunotherapy in advanced BRAFV600-positive melanoma: Long-term OS and final PFS results of the randomized phase II ImmunoCobiVem trial

在BRAFV600阳性晚期黑色素瘤中早期从靶向治疗转为免疫治疗:随机II期ImmunoCobiVem试验的长期OS和最终PFS结果

2024-09-011
PRE
Preliminary biomarker analysis in the phase III PIVOTAL study: Evidence for the mechanism of action of daromun in melanoma

III期PIVOTAL研究中的初步生物标志物分析:daromun在黑色素瘤中作用机制的证据

2024-09-010
PRE